Company profile
Pharmagen, Inc.
OTC: PHRX · Healthcare · Medical - Distribution
#1143 of 1,418 Healthcare companies by revenue
EA Score
——FH —DQ —GM —SS 39
v0.1 · 5/100 weight · pillars only
↑ listing tenure, operating margin · ↓ disclosure history, return on assets
Methodology →Revenue TTM
$4.8k
Rev growth YoY (TTM)
needs 8 qtrs
Net income (FY)
-$6.5k
Employees
24
as of 2026-08-03
Market cap
$5.2k
as of 2026-08-03
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$4.8k$4.8k2013
Net income-$6.5k-$6.5k2013
Operating income-$2.2k-$2.2k2013
Total assets$1.3k$1.3k2013
Liabilities$8.9k$8.9k2013
Equity-$7.6k-$7.6k2013
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Pharmagen, Inc.’s revenue?
Pharmagen, Inc. booked $4.8k in FY2013 revenue — among the slowest-growing Healthcare companies we track, at a -134.2% net margin.
Peers · Healthcare
Creative Medical Technology Holdings, Inc.46DAlaunos Therapeutics, Inc.33DOne World Products, Inc.——HeartSciences Inc.——Caring Brands, Inc.22DBiora Therapeutics, Inc.——Neighbors
Montgomery →Key facts
CEOMackie A. Barch
SectorHealthcare
IndustryMedical - Distribution
HeadquartersSilver Spring, MD
ExchangeOTC: PHRX
Employees24
IPO date2012-03-08
Latest filings
No filings loaded — no CIK (non-SEC filer).
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.